Search clinical trials for: PI3K Pathway

Total 2116 results

Assiut University

Not yet recruiting

PI3K Pathway Activation Markers in ER-Positive, HER2-Negative Breast Cancer: A Clinicopathologic Study (p-AKT p-S6)

Breast Cancer - ER+, HER2-, PIK3CA Gene Mutation
Terremoto Biosciences Inc.

Recruiting

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Cervical Cancer | Breast Cancer | Ovarian Cancer | Solid Tumor | Endometrial Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Lung Squamous Cell Carcinoma

United States, Puerto Rico, Portugal, Spain
Tianjin Medical University Second Hospital
Tianjin Medical University General Hospital; Tianjin First Central Hospital; The...

Not yet recruiting

Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency

Prostate Cancer

China
National Cancer Centre, Singapore
Novartis

Completed

A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR (BKM120)

Non-Small Cell Lung Cancer | Solid Tumors

Singapore
Medical Research Council
Merck Sharp & Dohme LLC; Aarhus University Hospital; NCRI Clinical Studies Groups and other collaborators

Unknown

Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475

Glioblastoma

United States, Italy, Belgium, Germany, Poland, Russian Federation, Spain, Switzerland, Ukraine, United Kingdom

Search clinical trials for: PI3K Pathway

This is a preview